CIITA and breast neoplasm: The ramifications of our study to tumors of the breast are clear and support previous findings regarding suppression of CIITA in breast cancer [42]: breast tumors may increase metastatic properties by epigenetically targeting CIITApIV resulting in suppression of cell surface expression of MHC II.